Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.58 -0.17 (-0.55%)
At close: Oct 21, 2026 · 4:00 PM EDT

Lakefront Biotherapeutics (LKFT) FCF Margin (2014 - 2026)

Updated

Lakefront Biotherapeutics (LKFT) reported FCF Margin of -1457.94% for the quarter ended Mar 31, 2026, down 1407.40 percentage points from -50.54% a year earlier and down 1425.28 percentage points from the prior quarter.

Analysis

Lakefront Biotherapeutics (LKFT) FCF Margin (2014 - 2026) Analysis & Trends

Over the twelve months ended Mar 31, 2026, Lakefront Biotherapeutics' FCF Margin came in at -36.68%, up 133.10 percentage points year-over-year; for the year ended Dec 31, 2025, it was -26.45%, up 118.86 percentage points from the prior year.

  • FCF Margin has a five-year change of +53.97 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, FCF Margin came in at -145.31% in the year ended Dec 31, 2024 (-52.45 pp), -92.86% in the year ended Dec 31, 2023 (-2.21 pp), -90.65% in the year ended Dec 31, 2022 (-89.87 pp) and -0.77% in the year ended Dec 31, 2021 (+79.65 pp).
  • The figure for the quarter ended Mar 31, 2026 ranks as the lowest quarterly FCF Margin since the quarter ended Jun 30, 2017.
  • Year over year, FCF Margin gained in four of the last six quarters, with an average year-over-year change of -144.45 percentage points.
  • The high point for year-over-year FCF Margin in five years was the quarter ended Dec 31, 2025 (a gain of 1035.45 percentage points); the low point was the quarter ended Mar 31, 2026 (a drop of 1407.40 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Mar 31, 2026 came in at -32.66% (quarter ended Dec 31, 2025), 4.01% (quarter ended Sep 30, 2025) and 6.36% (quarter ended Jun 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.82%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 18.33%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 26.96%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 38.60%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 6.55%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.70%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 44.00%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 2.01%
10 Lakefront Biotherapeutics 2.01 Bn 2.01 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,274.91%
Dec 31, 2025 -8.13%
Sep 30, 2025 4.01%
Jun 30, 2025 6.36%
Mar 31, 2025 -44.70%
Dec 31, 2024 -115.75%
Sep 30, 2024 2.60%
Mar 31, 2024 -190.11%
Dec 31, 2023 -161.24%
Sep 30, 2023 -328.23%
Jun 30, 2023 345.91%
Mar 31, 2023 14.74%
Sep 30, 2022 84.17%
Jun 30, 2022 108.68%
Mar 31, 2022 27.82%
Sep 30, 2021 118.91%
Jun 30, 2021 -165.51%
Mar 31, 2021 7.72%
Sep 30, 2020 121.84%
Jun 30, 2020 -266.76%
API Access

Lakefront Biotherapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=LKFT&period=max&api_key=YOUR_API_KEY